This review aims to examine the complex interaction between dyslipidemia, platelet function,
and related drug treatments. In particular, the manuscript provides an overview of the effects …

Abnormal lipid profile, increased glucose level, and elevated body weight are traditional
cardiometabolic risk factors; however, the role of platelets in the development of …

Background: Abnormal lipid metabolism predisposes to cardiovascular disease. However,
dyslipidemia is often asymptomatic leading to its underdiagnosis. Therefore, it is of utmost …

Deguelin (DGN), a retinoid isolated from many plants, exhibits a potent anticancer activity
against a wide spectrum of tumour cells. There is a dearth of evidence, however, regarding …

Ample evidence indicates that bufalin (BFN), a cardiotonic steroid in Bufo toad toxin,
possesses a potent anticancer activity mainly by stimulating apoptosis in cancer cells …

Increased cardiovascular risk has been associated with certain platelet morphological
parameters, and several single nucleotide polymorphisms (SNPs) have been reported to be …

Background There is a lack of noninvasive diagnostic methods for nonalcoholic
steatohepatitis (NASH), the severe condition of metabolic dysfunction‐associated steatotic …

Cardiometabolic risk factors, obesity, diabetes and hyperlipidemia contribute to
cardiovascular disease (CVD). While platelets are involved in CVD pathogenesis, the …

Hemophilia patients have a deficiency in or dysfunction of clotting factors, which can lead to
a bleeding tendency. However, paradoxically, some hemophilia patients may also be at an …

Despite the extensive use of combined antiretroviral therapy (cART) for effective human
immunodeficiency viral (HIV) suppression, people living with HIV have an increased risk of …